| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
908 Devices Inc.
13G/A
MASS · 65443P102
|
14.1% |
8/14/2026
Event 6/30/2026
|
||||
| ARCH Venture Fund VII, L.P. | 13.9% | |||||
| ARCH Venture Partners VII, L.P. | 13.9% | |||||
| ARCH Venture Partners VII, LLC | 13.9% | |||||
| Keith Crandell | 14.1% | |||||
| Clinton Bybee | 13.9% | |||||
| Robert Nelsen | 13.9% | |||||
|
Unity Biotechnology, Inc.
13G/A
UNBX · 91381U200
|
0% |
11/14/2025
Event 9/30/2025
|
||||
| ARCH Venture Fund VII, L.P. | 0% | |||||
| ARCH Venture Fund VIII Overage, L.P. | 0% | |||||
| ARCH Venture Partners VII, L.P. | 0% | |||||
| ARCH Venture Partners VII, LLC | 0% | |||||
| ARCH Venture Partners VIII, LLC | 0% | |||||
| Keith Crandell | 0% | |||||
| Clinton Bybee | 0% | |||||
| Robert Nelsen | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.